Sense Proteomic is discovers and commercializes autoantibody biomarkers for cancer and autoimmune diseases. It offers Kinome 2.0plus that is used by the pharmaceutical industry to screen kinase leads against human kinases. The company also provides biomarker panels for prostate cancer and lupus.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.